中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共4条，第1-4条

帮助

条数/页：排序方式：
	The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 8, 页码: 1338-1346 作者: Shi, Jia-jie; Chen, Si-meng; Guo, Chen-Liang; Li, Yi-xue; Ding, Jian \| 收藏 \| 浏览/下载：32/0 \| 提交时间：2019/01/08 tamoxifen resistance HSPB8 AZD8055 estrogen receptor mTOR inhibitor
	Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文 OAI收割 CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30 - \| 收藏 \| 浏览/下载：16/0 \| 提交时间：2020/10/26 PHASE-I POSTMENOPAUSAL WOMEN HDAC INHIBITOR MULTICENTER ENTINOSTAT TAMOXIFEN CS055/HBI-8000 RESISTANCE LETROZOLE TRIAL Advanced breast cancer hormone receptor-positive chidamide exemestane
	A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells 期刊论文 OAI收割 ONCOLOGY REPORTS, 2014, 卷号: 32, 期号: 2, 页码: 627-634 作者: Huang, Ou; Xie, Zuoquan; Zhang, Weili; Lou, Ying; Mao, Yan \| 收藏 \| 浏览/下载：17/0 \| 提交时间：2019/01/08 A771726 endocrine resistance tamoxifen apoptosis cell cycle microarray analysis
	Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 期刊论文 OAI收割 MOLECULES, 2013, 卷号: 18, 期号: 1, 页码: 701-720 作者: Jiang, Min; Huang, Ou \| 收藏 \| 浏览/下载：29/0 \| 提交时间：2019/01/08 curcumin endocrine resistance tamoxifen NF-kappa B Src/FAK Akt/mTOR EZH2 cyclin D1 c-Myc